Solo haz Sabio parásito nod mouse Molde Correspondiente yeso
NOD Mice (NOD/ShiLtJ) | Charles River
Frontiers | Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics
Bridge between type 1 diabetes in mouse and man | PNAS
NOD Mice | Non Obese Diabetic Mouse Model | Taconic Biosciences
NOD Mice Recapitulate the Cardiac Disturbances Observed in Type 1 Diabetes | SpringerLink
Cells | Free Full-Text | Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse
Diabetes in non‐obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells - Mellanby - 2007 - Immunology - Wiley Online Library
NOD Mice (NOD/ShiLtJ) | Charles River
Independent mechanisms underlie the protective effect of dietary polyunsaturated fatty acid supplementation and Gαz deficiency on the early type 1 diabetes phenotype of Non-obese diabetic (NOD) mice | bioRxiv
Sequencing of Idd regions in the NOD mouse genome
The Characteristics of NOD Mice - Maze Engineers
Exopolysaccharide from Leuconostoc pseudomesenteroides XG5 delay the onset of autoimmune diabetes by modulating gut microbiota and its metabolites SCFAs in NOD mice - ScienceDirect
Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes | PNAS
Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model - Schuster - 2018 - European Journal of Immunology - Wiley Online Library
001303 - NOD scid Strain Details
The 'skinny' on non-diabetic controls for non-obese diabetic (NOD) mice
Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain - ScienceDirect
Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice | Science
Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD mice | SpringerLink
IJMS | Free Full-Text | Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome